These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1087085)

  • 1. [Better characterization of antinuclear factors].
    Stojan B
    Verh Dtsch Ges Rheumatol; 1976; 4():427-32. PubMed ID: 1087085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Better characterization of antinuclear factors (proceedings)].
    Stojan B
    Z Rheumatol; 1976; 35 Suppl 4():suppl 427-32. PubMed ID: 790835
    [No Abstract]   [Full Text] [Related]  

  • 4. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The fall of blood complement level in pathology. Study of 50 cases].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jul; 1(28):1883-8. PubMed ID: 4115492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance and diagnostic value of different types of antinuclear antibodies demonstrated by immunofluorescence on smears of trypanosomed mice blood].
    Monier JC; Thivolet J; Sepetjian M; Beyvin AJ; Pousset G
    Lyon Med; 1970 May; 223(20):1007-18. PubMed ID: 4913277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA antibody determination in diffuse connective-tissue disease (author's transl)].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1626-7. PubMed ID: 4602107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Demonstration of antinuclear factors using the immunologic enzyme technic].
    Storch H
    Z Gesamte Inn Med; 1973 Jan; 28(2):29-32. PubMed ID: 4120838
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functional state of the blood coagulation system in patients with rheumatism and other collagenoses].
    Dashtaiants GA; Andrushchenko EV; Krasovskaia EA
    Vrach Delo; 1977 Jun; (6):32-4. PubMed ID: 302064
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic value of antinuclear antibodies with special reference to the immunofluorescent speckled pattern].
    Anger RD
    Z Hautkr; 1986 Nov; 61(21):1515-23. PubMed ID: 2433842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon reaction of leukocytes in diffuse connective tissue diseases].
    Pitenov VA; Etkind GV; Bektemirov TA; Alekberova ZS; Barinskiĭ IF
    Sov Med; 1976 Dec; (12):21-6. PubMed ID: 1013787
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
    Lee TK; Rothberger H
    Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.